<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00998816</url>
  </required_header>
  <id_info>
    <org_study_id>ANAE 153-09</org_study_id>
    <nct_id>NCT00998816</nct_id>
  </id_info>
  <brief_title>The Effect of Perioperative Pregabalin on the Incidence of Chronic Post-thoracotomy Pain Syndrome</brief_title>
  <official_title>A Multicenter Prospective Randomized Double-blind Placebo Controlled Trial Assessing the Effect of Perioperative Pregabalin on the Incidence of Chronic Post Thoracotomy Pain Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen's University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Queen's University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pregabalin, administered prior to and following lateral thoracotomy surgery will reduce the
      likelihood of chronic post-thoracotomy pain syndrome (CPTPS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 200 patients scheduled for lateral thoracotomy will be randomly assigned to
      receive either placebo or 150 mg pregabalin (Lyrica)1 hour prior to surgery, 12 hr after
      surgery and then every 12 hr for an additional 10 days. While in the hospital, patients will
      be assessed for pain intensity, satisfaction and side effects. Patients will be re-assessed
      at 2, 4 and 6 months following surgery.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No funding
  </why_stopped>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of chronic post thoracotomy pain syndrome</measure>
    <time_frame>6 months following surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>During hospital stay: pain intensity, PEF and FEV1, patient satisfaction, medication side effects. At 2, 4, and 6 months: pain intensity, pain quality (neuropathic versus other), quality of life, pain interference with daily function</measure>
    <time_frame>During hospital stay and at 2, 4, and 6 months postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Placebo capsules</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>one placebo capsule will be administered 1 hour before lateral thoracotomy, 12 hours following the thoracotomy and then every 12h BID for 10 days following lateral thoracotomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pregabalin capsules</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pregabalin capsules (150mg) will be administered one hour before lateral thoracotomy, 12 hours following the thoracotomy and then every 12 hours (BID) for 10 days following lateral thoracotomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>pregabalin capsules (150mg,oral) will be administered 1 hour before lateral thoracotomy, 12 hours after the thoracotomy and then 12 h BID for 10 additional days.</description>
    <arm_group_label>Placebo capsules</arm_group_label>
    <arm_group_label>pregabalin capsules</arm_group_label>
    <other_name>Lyrica</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective open thoracotomy for primary thoracic surgery, understanding and provision of
             written informed consent, ASA class I II or III

        Exclusion Criteria:

          -  Inability ot adhere to study protocol:

               -  intolerance or hypersensitivity to any agents to be used in the study,
                  contraindication to thoracic epidural placement

               -  inability to respond to the study questionnaire

               -  renal insufficiency(serum creatinine &gt; 1.5 upper limit of normal)

               -  Body Mass index &gt; 40

               -  planned post-operative ventilation.

          -  Confounding procedural factors which might affect validity of data:

               -  previous ipsilateral thoracotomy

               -  surgery for tumor extending into the chest wall

               -  rest pain in proposed surgical area pre-operatively

               -  chest tube in situ at time of surgery

               -  requirement for second thoracotomy or re-occurrence of disease after surgery
                  *isolated pleuroscopy or pleurodesis procedures.

          -  Potential interaction with study medications and patient's current medications:

               -  current alcohol or other substance abuse

               -  chronic steroid use

               -  pre-existing chronic pain requiring chronic analgesic use

               -  history of seizure disorder requiring treatment with an anticonvulsant

               -  current therapy with thiazolidinedione class oral hypoglycemic agents (eg, Actos,
                  Avandia or Avandamet)

               -  history of congestive heart failure

               -  major psychiatric disorder

               -  any contraindication to use of NSAIDs.

          -  Insufficient safety data in the patient population:

               -  patients requiring preoperative assistance or assistive device for ambulation,
                  pregnant or breastfeeding

               -  weight &lt;50 Kg

               -  dizziness while inpatient.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jorge E Zamora, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen's University/ Kingston General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Jorge E Zamora</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 2V7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2009</study_first_submitted>
  <study_first_submitted_qc>October 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2009</study_first_posted>
  <last_update_submitted>April 10, 2012</last_update_submitted>
  <last_update_submitted_qc>April 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen's University</investigator_affiliation>
    <investigator_full_name>Jorge Zamora</investigator_full_name>
    <investigator_title>Associate Professor, MD, FRCPC</investigator_title>
  </responsible_party>
  <keyword>thoracotomy</keyword>
  <keyword>chronic</keyword>
  <keyword>pain</keyword>
  <keyword>pregabalin</keyword>
  <keyword>Lyrica</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

